HMPC: overview of assessment work - priority list
HMPC: overview of assessment work - priority list
HMPC: overview of assessment work - priority list
Minimum inhibitory concentration (MIC) breakpoints
Referral: Hydroxyprogesterone-containing medicinal products, hydroxyprogesterone, associated names: Lentogest,Progesterone Retard Pharlon,Proluton Depot Article 31 referrals Under evaluation, 09/02/2024
Herbal medicinal product: Matricariae aetheroleumArray, F: Assessment finalised
Herbal medicinal product: Lecithinum ex soyaArray, D: Draft under discussion
Herbal medicinal product: Cnici benedicti herbaArray, F: Assessment finalised
Meeting summary of the Medicine Shortages (SPOC) Working Party 14 December 2023
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 February 2024
Joint HMA/EMA multi-stakeholder workshop on Patient Registries
Human medicines highlights - February 2024